LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹472 Cr | ₹394 Cr | ₹346 Cr | ₹295 Cr | ₹262 Cr |
What is the latest Net Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹472 Cr |
| Mar2025 | ₹394 Cr |
| Mar2024 | ₹346 Cr |
| Mar2023 | ₹295 Cr |
| Mar2022 | ₹262 Cr |
How is Net Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹472 Cr | 19.88 | |
| Mar2025 | ₹394 Cr | 13.96 | |
| Mar2024 | ₹346 Cr | 17.09 | |
| Mar2023 | ₹295 Cr | 12.47 | |
| Mar2022 | ₹262 Cr | - | |
Compare Net Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,023.8 Cr | -1.9% | -0.8% | -2.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -1.9% |
-0.8% |
-2.2% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses